CVS Health Corporation is an American healthcare company that owns CVS Pharmacy, a retail pharmacy chain; CVS Caremark, a pharmacy benefits manager; and Aetna, a health insurance provider, among many other brands.
Company profile
Ticker
CVS
Exchange
Website
CEO
Larry Merlo
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
Former names
CVS CAREMARK CORP, CVS CORP, CVS/CAREMARK CORP, MELVILLE CORP
SEC CIK
Corporate docs
Subsidiaries
CVS Foreign, Inc. • ◦CVS Caremark Indemnity Ltd. • ◦CVS International, Inc. • CVS Pharmacy, Inc. • Aetna Inc. • ◦Aetna Health Holdings, LLC • ◦Aetna Health of California Inc. • ◦Aetna Health Inc. • ◦Aetna Health of Michigan Inc. • ▪Aetna Better Health Inc. ...
IRS number
50494040
CVS stock data
Latest filings (excl ownership)
PX14A6G
Letter to shareholders
16 Apr 24
ARS
2023 FY
Annual report to shareholders
5 Apr 24
DEFA14A
Additional proxy soliciting materials
5 Apr 24
DEF 14A
Definitive proxy
5 Apr 24
8-K
Regulation FD Disclosure
5 Mar 24
10-K
2023 FY
Annual report
7 Feb 24
8-K
Results of Operations and Financial Condition
7 Feb 24
8-K
CVS Health Announces Leadership Appointments
5 Jan 24
8-K
CVS Health highlights path to accelerating long-term growth
5 Dec 23
10-Q
2023 Q3
Quarterly report
1 Nov 23
Transcripts
CVS
Earnings call transcript
2023 Q4
7 Feb 24
CVS
Earnings call transcript
2023 Q3
1 Nov 23
CVS
Earnings call transcript
2023 Q2
2 Aug 23
CVS
Earnings call transcript
2023 Q1
3 May 23
CVS
Earnings call transcript
2022 Q4
8 Feb 23
CVS
Earnings call transcript
2022 Q3
2 Nov 22
CVS
Earnings call transcript
2022 Q2
3 Aug 22
CVS
Earnings call transcript
2022 Q1
4 May 22
CVS
Earnings call transcript
2021 Q4
9 Feb 22
CVS
Earnings call transcript
2021 Q3
3 Nov 21
Financial summary
Quarter (USD) | Sep 23 | Jun 23 | Mar 23 | Dec 22 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 22 | Dec 21 | Dec 20 | Dec 19 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 13.38 bn | 13.38 bn | 13.38 bn | 13.38 bn | 13.38 bn | 13.38 bn |
Cash burn (monthly) | 250.67 mm | 349.00 mm | (no burn) | (no burn) | (no burn) | (no burn) |
Cash used (since last report) | 1.70 bn | 2.37 bn | n/a | n/a | n/a | n/a |
Cash remaining | 11.67 bn | 11.00 bn | n/a | n/a | n/a | n/a |
Runway (months of cash) | 46.6 | 31.5 | n/a | n/a | n/a | n/a |
Institutional ownership, Q4 2023
60.5% owned by funds/institutions
13F holders | Current |
---|---|
Total holders | 1862 |
Opened positions | 243 |
Closed positions | 429 |
Increased positions | 552 |
Reduced positions | 899 |
13F shares | Current |
---|---|
Total value | 57.04 tn |
Total shares | 762.15 mm |
Total puts | 4.22 mm |
Total calls | 3.25 mm |
Total put/call ratio | 1.3 |
Largest owners | Shares | Value |
---|---|---|
Vanguard | 117.70 mm | $9.29 tn |
STT State Street | 55.20 mm | $4.36 tn |
Capital World Investors | 40.54 mm | $3.20 tn |
FMR | 37.82 mm | $2.99 tn |
Capital International Investors | 33.69 mm | $2.66 tn |
MS Morgan Stanley | 30.62 mm | $2.42 tn |
Dodge & Cox | 30.41 mm | $2.40 tn |
IVZ Invesco | 15.96 mm | $1.26 tn |
JPM JPMorgan Chase & Co. | 13.77 mm | $1.09 tn |
NTRS Northern Trust | 13.69 mm | $1.08 tn |
Recent insider trades
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
1 Apr 24 | Lynch Karen S | Common Stock | Payment of exercise | Dispose F | No | No | 79.56 | 61,953 | 4.93 mm | 74,687 |
1 Apr 24 | Lynch Karen S | Common Stock (Restricted) | Grant | Acquire A | No | No | 79.56 | 45,248 | 3.60 mm | 45,248 |
1 Apr 24 | Lynch Karen S | Stock Option Common Stock | Grant | Acquire A | No | No | 79.56 | 188,087 | 14.96 mm | 188,087 |
1 Apr 24 | Tilak Mandadi | Common Stock (RSU) | Grant | Acquire A | No | No | 0 | 16,339 | 0.00 | 82,904 |
1 Apr 24 | Tilak Mandadi | Stock Option Common Stock | Grant | Acquire A | No | No | 79.56 | 67,920 | 5.40 mm | 67,920 |
1 Apr 24 | Prem S Shah | Common Stock (Restricted) | Grant | Acquire A | No | No | 0 | 15,082 | 0.00 | 37,057 |
1 Apr 24 | Prem S Shah | Common Stock | Payment of exercise | Dispose F | No | No | 79.56 | 5,239 | 416.81 k | 42,034.463 |
1 Apr 24 | Prem S Shah | Common Stock | Payment of exercise | Dispose F | No | No | 79.56 | 2,653 | 211.07 k | 47,273.463 |
1 Apr 24 | Prem S Shah | Stock Option Common Stock | Grant | Acquire A | No | No | 79.56 | 62,695 | 4.99 mm | 62,695 |
1 Apr 24 | Khichi Samrat S. | Common Stock (Restricted) | Grant | Acquire A | No | No | 0 | 12,569 | 0.00 | 44,490 |
News
Freeport-McMoRan, AppLovin And A Major Healthcare Stock On CNBC's 'Final Trades'
17 Apr 24
See How Florida's Much Awaited Medicaid Re-Procurement Awards Impact Centene, Humana, Molina
15 Apr 24
Cantor Fitzgerald Reiterates Overweight on CVS Health, Maintains $87 Price Target
10 Apr 24
Dow Endures Rocky Start to Second Quarter
8 Apr 24
Wells Fargo Maintains Equal-Weight on CVS Health, Lowers Price Target to $76
8 Apr 24
Press releases
Aetna Better Health of Michigan recommended for CHCP contract
9 Apr 24
CVS Health® expands pharmacy tuition assistance and scholarship programs
3 Apr 24
CVS Health® invests more than $3M in organizations improving health outcomes in Phoenix
27 Mar 24
CVS Health announces quarterly dividend
21 Mar 24
FSD Pharma: A Compelling Value Proposition As UNBUZZD™ Positions To Dominate The Alcohol-Detox Functional Beverage Market
14 Mar 24